Month: April 2017
-
Engineered Bacteria Designed to Detect Gut Inflammation
A bioengineering team at Rice University developed a genetically modified form of bacteria that in lab mice detects inflammatory diseases in the gut.
-
Antibody Shows Promise Against Marburg Virus Infections
Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections.
-
FDA Shown Approving New Drugs Faster than Europe
An analysis of regulatory actions in the U.S. and Europe, shows the U.S. Food and Drug Administration approves more new therapies and faster than the European Medicines Agency.
-
Umbilical Cord Blood Evaluated for Autism Treatment
Results from a clinical trial show infusions of a child’s own umbilical cord blood are safe for treating autism spectrum disorder, and provide initial signs of effectiveness.
-
Prodrugs Designed to Better Target Cancer Therapies
A delivery mechanism is being developed to package cancer drugs in a nanoscale precursor state that reacts only in tumor regions, to protect against adverse effects.
-
Artificial Pancreas Shown Feasible for Young Children
An integrated system combining a glucose monitor and insulin pump to simulate the human pancreas is shown to be feasible for young children with type 1 diabetes.
-
Triple-Drug Inhaler Shown to Cut COPD Attacks
Results from a year-long clinical trial show that an inhaler with three types of drugs reduces the number of COPD attacks compared to a common single-drug inhaler.
-
Enhanced Gene Therapy Boosts Anti-Tumor Response
Gene therapies delivered with electronic pulses were shown in lab mice to increase production of natural immune-system proteins and reduce melanoma, or advanced skin cancer, tumors.
-
Zika DNA Vaccine Begins Clinical Trial
A new clinical trial is underway testing a Zika vaccine that uses genetically-engineered DNA to generate an immune response against the disease.